SI1007097T1 - Formulation of stabilised cationic transfection agent(s)/nucleic acid particles - Google Patents

Formulation of stabilised cationic transfection agent(s)/nucleic acid particles

Info

Publication number
SI1007097T1
SI1007097T1 SI9830073T SI9830073T SI1007097T1 SI 1007097 T1 SI1007097 T1 SI 1007097T1 SI 9830073 T SI9830073 T SI 9830073T SI 9830073 T SI9830073 T SI 9830073T SI 1007097 T1 SI1007097 T1 SI 1007097T1
Authority
SI
Slovenia
Prior art keywords
formulation
nucleic acid
acid particles
transfection agent
cationic transfection
Prior art date
Application number
SI9830073T
Other languages
Slovenian (sl)
Inventor
Joel Crouzet
Bruno Pitard
Original Assignee
Aventis Pharma S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from FR9701467A external-priority patent/FR2759298B1/en
Application filed by Aventis Pharma S.A. filed Critical Aventis Pharma S.A.
Publication of SI1007097T1 publication Critical patent/SI1007097T1/en

Links

SI9830073T 1997-02-10 1998-02-06 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles SI1007097T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9701467A FR2759298B1 (en) 1997-02-10 1997-02-10 FORMULATION OF CATIONIC TRANSFECTING AGENT (S) / NUCLEIC ACID PARTICLES
EP98906986A EP1007097B1 (en) 1997-02-10 1998-02-06 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
PCT/FR1998/000222 WO1998034648A1 (en) 1997-02-10 1998-02-06 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles

Publications (1)

Publication Number Publication Date
SI1007097T1 true SI1007097T1 (en) 2002-02-28

Family

ID=26152416

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830073T SI1007097T1 (en) 1997-02-10 1998-02-06 Formulation of stabilised cationic transfection agent(s)/nucleic acid particles

Country Status (1)

Country Link
SI (1) SI1007097T1 (en)

Similar Documents

Publication Publication Date Title
AU8525098A (en) Liposomal compositions for the delivery of nucleic acid catalysts
HUP0002877A3 (en) Stable insulin formulations and process for their preparation
EP1014790A4 (en) Chemical modification of dna using peptide nucleic acid conjugates
HK1010150A1 (en) Liquid gonadotropin containing formulations
ZA988886B (en) Formulation for treatment of osteoporosis
EG24044A (en) pharmaceutical formulation of omeprazole
HUP0004534A3 (en) Pharmaceutical formulation containing olanzapine
HUP0103707A3 (en) Formulation of stable oxalyplatinum solution
GB9726916D0 (en) Nasal formulation
PL338633A1 (en) Derivatives of aryloxyarylsuphonylamino hydroxamic acid
HUP0001094A3 (en) Process for stabilization of naloxone and stable pharmaceutical compositions containing naloxone
ZA982872B (en) Pharmaceutical formulation
HUP0001720A3 (en) Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
ZA9810316B (en) Phosphonic acid-substituted benzazepinone-N-acetic acid derivatives and processes for their preparation and pharmaceuticals comprising these compounds
PL325821A1 (en) Liquid acid netralising preparation
GB9710800D0 (en) Pharmaceutical composition and method of preparing it
IL130886A0 (en) Nucleic acid sequencing
IL123849A0 (en) Pharmaceutical composition useful for nucleic acid transfection and use thereof
PL327786A1 (en) Pharmaceutical preparations of cilansterone stabilised against racemisation
HUP0004577A3 (en) Novel class of nucleic acid cationic transfecting agents
IL136917A0 (en) Stabilization of lipid:dna formulations during nebulization
SI1007097T1 (en) Formulation of stabilised cationic transfection agent(s)/nucleic acid particles
EP1161547A4 (en) Intravascular delivery of non-viral nucleic acid
IL127691A0 (en) Useful formulations of acid addition salt drugs
GB9717932D0 (en) Estimation of nucleic acid